For Research Use Only. MOTS-c is intended strictly for in vitro and preclinical animal research. It is not approved for human use, is not a drug, and should never be administered to humans.
The Published MOTS-c Pharmacology That Drives Sourcing Standards
MOTS-c is a 16-amino-acid peptide (sequence MRWQEMGYIFYPRKLR) encoded within the mitochondrial 12S ribosomal RNA region rather than the nuclear genome. The unusual encoding pattern is the reason sequence verification is so critical for research-grade supply. Standard solid-phase peptide synthesis can introduce deletion sequences, isomerized residues, and incomplete amidation products that share retention time and parent mass with the target compound but lack the specific biological activity that distinguishes MOTS-c from related short peptides.
The molecule's primary published mechanism of action centers on skeletal muscle. The seminal characterization study by Lee et al., Cell Metabolism (Cell Press), 2015 reported that MOTS-c administration in mice prevented age-dependent and high-fat-diet-induced insulin resistance, with the mechanistic locus traced to AMP-activated protein kinase (AMPK) activation in skeletal muscle and corresponding upregulation of GLUT4-mediated glucose uptake. The same study established that MOTS-c functions as a circulating mitokine, providing a measurable plasma readout for in vivo dose-response work.
A follow-up study published in Reynolds et al., Nature Communications, 2021 connected MOTS-c expression to exercise-induced muscle homeostasis and age-dependent physical decline in mouse models, showing that exercise increases endogenous MOTS-c expression in skeletal muscle and circulation, and that exogenous MOTS-c administration in aged mice partially restored muscle performance metrics. For laboratories planning rodent dose-finding studies, the published intraperitoneal dosing range that produced these effects (typically 0.5 to 5 mg/kg) anchors the design of pharmacokinetic and tissue-distribution work.
Why These Mechanisms Make Quality Documentation Non-Negotiable
The AMPK-mediated mechanism above produces a quantifiable downstream phenotype (increased phospho-AMPK Thr172, GLUT4 membrane translocation, enhanced 2-deoxyglucose uptake in cultured myotubes) that researchers can use to bench-test the biological activity of a received MOTS-c lot. A laboratory ordering MOTS-c without sequence-confirmed identity has no way to distinguish between a failed receptor response (because the peptide is inactive) and a true negative biological finding. Sequence verification by tandem mass spectrometry on every lot is the documentation step that makes this distinction possible at the bench.
The exercise-mitokine biology adds a second analytical concern. Endogenous MOTS-c circulates at low nanomolar concentrations and is measured by ELISA in published studies. Investigators benchmarking exogenous administration against endogenous levels need accurate counterion accounting and water-of-hydration data to convert lyophilized vial mass to actual peptide content, with errors on the order of 10 to 20 percent translating directly into miscalibrated comparisons against physiological reference ranges.
For research-grade MOTS-c supply, the documentation package should include HPLC area-percent purity, ESI-MS or MALDI-TOF confirmation of monoisotopic mass (calculated mass for the unmodified 16-mer is approximately 2174.5 Da), MS/MS sequence confirmation showing the complete fragmentation pattern, counterion identification (typically trifluoroacetate or acetate), and endotoxin results for any lot intended for cell culture or animal model use. The combination supports both bench-level quality verification and meaningful cross-comparison against the published reference literature.
What Research Grade MOTS-c Supply Requires
MOTS-c is a sixteen amino acid peptide encoded by the mitochondrial genome rather than the nuclear genome. The sequence is defined in the published literature and has specific biological activity that is distinct from related mitochondrial derived peptides. Research grade supply has to confirm the correct sequence identity because even single amino acid substitutions can produce substantially different biological activity.
The analytical characterization of MOTS-c includes HPLC purity assessment, mass spectrometric identification, and tandem mass spectrometric sequencing. The sequence verification is particularly important for this peptide because the specific amino acid composition has been characterized in relation to its biological activity profile.
Midwest Peptide supplies MOTS-c 10mg with third party certificates of analysis that address these requirements.
Sourcing Criteria for Research Grade MOTS-c
Third party certificate of analysis. Independent analytical verification with lot specific values.
Purity specification. Research grade MOTS-c is supplied at a minimum of ninety five percent HPLC purity.
Mass confirmation. Mass spectrometric analysis confirming the correct peptide mass.
Sequence verification. Tandem mass spectrometry confirming the specific sixteen amino acid sequence.
Lot traceability. Every vial carries a lot number that traces to the production batch.
Research use only compliance. The MOTS-c research cluster covers the preclinical research applications including mitochondrial derived peptide discovery, AMPK pathway research, exercise research, aging research, insulin sensitivity research, and obesity research.
Shipping. Domestic shipping from Mission, Kansas through ShipStation and UPS.
Payment flexibility. Zelle (five percent discount), CashApp, Venmo, Azeban Pay, and Coinbase Commerce.
Research support. Direct support through 636-734-2390.
Red Flags When Evaluating MOTS-c Suppliers
No sequence confirmation. A certificate showing only mass without sequence confirmation is inadequate for a peptide where sequence specificity is critical.
Purity below research grade or unspecified. Ninety five percent HPLC purity minimum with lot specific values.
Internal certificate only. Third party verification is the research grade standard.
Health claims or implied human use. Suppliers making such claims operate outside the research use only framework.
Opaque supplier. Legitimate research peptide suppliers have known physical locations.
What MOTS-c Is Studied For in Research
The MOTS-c research cluster covers the full landscape. The short summary is that MOTS-c is studied in cellular and rodent research models for effects on AMPK pathway activation, skeletal muscle glucose uptake and insulin sensitivity, exercise metabolism, aging phenotypes and longevity endpoints, body composition in obesity models, and mitochondrial function across tissues.
Related research with other metabolic peptides is supported by the parallel Midwest Peptide catalog offerings. The GLP-1 SM 20mg, GLP-2 TZ 30mg, and GLP-3 RT products provide incretin receptor agonists for related metabolic research. The NAD+ 500mg product provides the mitochondrial cofactor that intersects with MOTS-c biology. The Tesamorelin 10mg and Cagrilintide 5mg products provide additional metabolic research peptides.